The Business Times
The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

SUBSCRIBERS

Drugmaker Mylan's woes get worse with president engulfed in vast probe

He is one of those accused of colluding in conspiracy to prop up prices

Published Wed, Nov 1, 2017 · 09:50 PM
Share this article.

San Francisco

MYLAN NV's latest troubles couldn't come at a worse time.

Two years ago, Mylan was a swaggering drugmaker on the way up, buying up rivals as it grew and diversified.

Then it faced political scrutiny over price hikes for its EpiPen allergy shot and increasing pressure on prices for the generic drugs that are the company's backbone.

In August, Mylan cut its 2018 outlook, and on Tuesday came another blow: its N…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here